157 filings
Page 6 of 8
8-K
vpt 8h090
7 Aug 19
Company successfully completed the first of two planned human factors studies
8:13am
8-K
5kk2 eo7vslej2tsor
20 Jun 19
Submission of Matters to a Vote of Security Holders
5:04pm
8-K
e9qnyc8srrd
4 Jun 19
Entry into a Material Definitive Agreement
4:47pm
8-K
gfsiz5v1c8nh7etjfq2
8 May 19
Provides Business Update
8:10am
DEFA14A
sj5ouoz619 u08qccgt
30 Apr 19
Additional proxy soliciting materials
4:22pm
8-K
rwmet6rt cg
21 Mar 19
Signed development agreement with West Pharmaceutical Services for next-generation FUROSCIX®On-Body Infusor
8:06am
EFFECT
py5zmase 0d
11 Feb 19
Notice of effectiveness
12:00am
UPLOAD
ez4zp4vsxsta2br75
8 Feb 19
Letter from SEC
12:00am
CORRESP
ljietj74
7 Feb 19
Correspondence with SEC
12:00am
8-K
0fczlkr4bff3kul9p2
29 Jan 19
Entry into a Material Definitive Agreement
8:06am
S-8
70fliqs
3 Jan 19
Registration of securities for employees
4:23pm
S-3
jfygd2
3 Jan 19
Shelf registration
4:16pm
8-K
a3pyhfrsv tmrppq
3 Jan 19
Index to Financial Statements
4:12pm
8-K
g14odk7dwuqovx25i
27 Nov 18
Entry into a Material Definitive Agreement
4:15pm
8-K
klxqv s92ge2q7hqceq
13 Nov 18
Results of Operations and Financial Condition
8:10am
8-K
fpzo2vubbsbgk
22 Oct 18
Departure of Directors or Certain Officers
8:00am